Alzheimer's expressed differently in carriers and noncarriers of the Alzheimer’s gene

July, 2010

A new study reveals that having the 'Alzheimer's gene' doesn't simply increase your risk of developing Alzheimer's, but affects how the brain is damaged.

A comprehensive study reveals how the ‘Alzheimer's gene’ (APOE ε4) affects the nature of the disease. It is not simply that those with the gene variant tend to be more impaired (in terms of both memory loss and brain damage) than those without. Different parts of the brain (and thus different functions) tend to be differentially affected, depending on whether the individual is a carrier of the gene or not. Carriers displayed significantly greater impairment on tests of memory retention, while noncarriers were more impaired on tests of working memory, executive control, and lexical access. Consistent with this, carriers showed greater atrophy in the mediotemporal lobe, and noncarriers greater atrophy in the frontoparietal area. The findings have implications both for diagnosis and treatment.

http://www.eurekalert.org/pub_releases/2010-05/uops-nsc051410.php

Reference:

[1594] Wolk, D. A., & Dickerson B. C.
(2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease.
Proceedings of the National Academy of Sciences. 107(22), 10256 - 10261.

seniors

genes

Alzheimers

Related News

Untreated vision problems linked to dementia in the elderly

Data from 625 elderly Americans, followed for an average of 8.5 years, has revealed that those with very good or excellent vision at the beginning of the study had a 63% reduced risk of dementia over the study period.

Alzheimer's memory problems originate with oligomers not plaques

While everyone agrees that amyloid-beta protein is part of the problem, not everyone agrees that amyloid plaques are the cause (or one of them) of Alzheimer’s. Other forms of amyloid-beta have been pointed to, including floating clumps called oligomers or ADDLs.

More evidence for benefits of Rapamycin

A few months ago, I reported on an exciting finding that

New guideline on when people with Alzheimer's disease should stop driving

The American Academy of Neurology has updated its guidelines on when people with dementia should stop driving.

New gene associated with increased risk of Alzheimer's

Another gene has been identified that appears to increase risk of Alzheimer’s. The gene, MTHFD1L, is located on chromosome six.

Losing muscle mass early sign of Alzheimer’s

Previous research has found that unexplained weight loss is an early sign of Alzheimer's.

Memory problems not the only predictor of later mild cognitive impairment

Amnestic mild cognitive impairment often leads to Alzheimer's disease, but what predicts aMCI?

Apple juice improves behavior in Alzheimer's patients

A pilot study involving 21 institutionalized individuals with moderate-to-severe Alzheimer’s found that, although drinking two 4-oz glasses of apple juice daily for a month produced no change in the Dementia Rating Scale or in the Activities of Daily Living measure, there was a significant (27%)

TMS improves language comprehension in Alzheimer's sufferers

A pilot study involving 10 patients with moderate Alzheimer's disease, of whom half were randomly assigned to the treatment, has found that two weeks of receiving daily (25 minute) periods of repetitive transcranial magnetic stimulation to the prefrontal

Common Alzheimer's medication helps skills necessary for safe driving

A study involving outpatients with early stage Alzheimer’s found that their performance on some computerized tests of executive function and visual attention, including a simulated driving task, improved significantly after three months of taking

Pages